Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis W Lendrem

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Drug Discovery Today|December 19, 2012
Torching the Haystack: modelling fast-fail strategies in drug developmentDennis W Lendrem, B Clare Lendrem
Drug Discovery Today|September 21, 2013
The development speed paradox: can increasing development speed reduce R&D productivity?Dennis W Lendrem, B Clare Lendrem
Expert Review of Clinical Immunology|May 28, 2020
In search of pathobiological endotypes: a systems approach to early rheumatoid arthritisJessica R Tarn, Dennis W Lendrem, John D Isaacs
The Journal of Sexual Medicine|April 5, 2023
Coping strategies, illness perceptions, and relationship dynamics contribute to female sexual function and sexual distress in Sjögren's syndromeJemma L McCready, Vincent Deary, Tracy L Collins, et al.
Nature Reviews. Drug Discovery|August 22, 2015
Why is it hard to terminate failing projects in pharmaceutical R&D?Richard W Peck, Dennis W Lendrem, Iain Grant, et al.
Rheumatology (Oxford, England)|February 13, 2019
Routine musculoskeletal ultrasound findings impact diagnostic decisions maximally in autoantibody-seronegative early arthritis patientsKundan Iqbal, Dennis W Lendrem, Ben Hargreaves, et al.
Therapeutic Advances in Musculoskeletal Disease|June 12, 2020
Lack of association between clinical and ultrasound measures of disease activity in rheumatoid arthritis remissionKenneth F Baker, Ben Thompson, Dennis W Lendrem, et al.
Clinical Proteomics|August 13, 2021
Robust optimization of SWATH-MS workflow for human blood serum proteome analysis using a quality by design approachEdith Serrano-Blesa, Andrew Porter, Dennis W Lendrem, et al.
Drug Discovery Today|December 14, 2019
Schrödinger's pipeline and the outsourcing of pharmaceutical innovationPeter McMeekin, Dennis W Lendrem, B Clare Lendrem, et al.
Nature Reviews. Drug Discovery|February 7, 2015
Progression-seeking bias and rational optimism in research and developmentDennis W Lendrem, B Clare Lendrem, Richard W Peck, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Drug Discovery Today|December 19, 2012
Torching the Haystack: modelling fast-fail strategies in drug developmentDennis W Lendrem, B Clare Lendrem
Drug Discovery Today|September 21, 2013
The development speed paradox: can increasing development speed reduce R&D productivity?Dennis W Lendrem, B Clare Lendrem
Expert Review of Clinical Immunology|May 28, 2020
In search of pathobiological endotypes: a systems approach to early rheumatoid arthritisJessica R Tarn, Dennis W Lendrem, John D Isaacs
The Journal of Sexual Medicine|April 5, 2023
Coping strategies, illness perceptions, and relationship dynamics contribute to female sexual function and sexual distress in Sjögren's syndromeJemma L McCready, Vincent Deary, Tracy L Collins, et al.
Nature Reviews. Drug Discovery|August 22, 2015
Why is it hard to terminate failing projects in pharmaceutical R&D?Richard W Peck, Dennis W Lendrem, Iain Grant, et al.
Rheumatology (Oxford, England)|February 13, 2019
Routine musculoskeletal ultrasound findings impact diagnostic decisions maximally in autoantibody-seronegative early arthritis patientsKundan Iqbal, Dennis W Lendrem, Ben Hargreaves, et al.
Therapeutic Advances in Musculoskeletal Disease|June 12, 2020
Lack of association between clinical and ultrasound measures of disease activity in rheumatoid arthritis remissionKenneth F Baker, Ben Thompson, Dennis W Lendrem, et al.
Clinical Proteomics|August 13, 2021
Robust optimization of SWATH-MS workflow for human blood serum proteome analysis using a quality by design approachEdith Serrano-Blesa, Andrew Porter, Dennis W Lendrem, et al.
Drug Discovery Today|December 14, 2019
Schrödinger's pipeline and the outsourcing of pharmaceutical innovationPeter McMeekin, Dennis W Lendrem, B Clare Lendrem, et al.
Nature Reviews. Drug Discovery|February 7, 2015
Progression-seeking bias and rational optimism in research and developmentDennis W Lendrem, B Clare Lendrem, Richard W Peck, et al.
Pageof 4